92 statistical programming jobs at 63 companies in East Providence, RI
1w
Save
Mark Applied
Hide
1w
Director, Statistical Programming
Madison or Princeton or Cambridge
$217k-$294k/yrOnsiteFull Time
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
10+ YOEMS (10+ yrs) or BS (12+ yrs) industry experience; proven leadership in statistical programming, drug development operational experience, talent attraction/retention, and expertise in clinical trial programming and regulatory standards.
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
10+ YOE7+ Mgmt10+ years statistical programming experience, 7+ years people/project management, advanced SAS skills, knowledge of CDISC SDTM/ADaM and eCTD submissions, budget and vendor management, leadership and cross-functional collaboration.
BiogenNASDAQ: BIIB: Biogen develops therapies for neurological and neurodegenerative diseases.
2+ YOEBachelor's required (Masters preferred) in statistics/math/CS,2+ years relevant experience,2+ years SAS Base programming (STAT, GRAPH, MACRO),CDISC/submissions experience,UNIX and R familiarity,knowledge of clinical trials and regulatory submissions.
SAS Base, SAS STAT, SAS GRAPH, SAS MACRO, CDISC, define.xml, XPT, UNIX, R, WinNonLin, NONMEM
Bicycle TherapeuticsNASDAQ: BCYC: Developing synthetic peptide medicines for oncology and other diseases.
Expert statistical programming in biotech/pharma, SAS and CDISC (SDTM/ADaM) experience, regulatory submission preparation, CRO/vendor management, leadership and strategic planning for clinical programs.
RegeneronNasdaq: REGN: Discovers and manufactures medicines for serious diseases.
10+ YOEAdvanced SAS programming in clinical data, understanding of clinical trial/statistical and regulatory submission requirements, proven project and people leadership, mentoring experience, 10+ years programming experience.
AlnylamNasdaq: ALNY: Developing and commercializing RNA interference (RNAi) therapeutics for diseases.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, experience leading programming teams, CDISC (SDTM/ADaM) knowledge, proficiency in R and SAS, strong communication and organization.
King of Prussia or Maidenhead or Waltham or Glattbrugg
$239k-$308k/yrOnsiteFull Time
CSLASX: CSL: Develops and manufactures biopharmaceutical products and vaccines.
10+ YOE5+ MgmtBSc in Computer Science/Math/Statistics or equivalent, 10+ years industry experience in biotech/pharma/CRO, 5+ years supervisory experience preferred, advanced SAS and CDISC knowledge, CRO management experience, strong communication and leadership skills.
Servier: Independent global pharmaceutical group developing innovative treatments for patients.
5+ YOEMasters degree, 5+ years statistical programming/biostatistics in pharma/biotech, proficient in SAS, CDISC SDTM/ADaM, regulatory knowledge, study management and programmer oversight.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, CDISC SDTM/ADaM expertise, leadership experience, proficiency with R, strong communication and regulatory submission experience. Bachelor's required; Master's preferred.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
10+ YOELead strategic direction of statistical programming; 10+ years in programming strategy; AI/automation; leadership; outsourcing experience; CDISC standards.
Kura OncologyNASDAQ: KURA: Develops precision small molecule medicines for cancer treatment.
10+ YOE10+ years clinical programming experience; MS (or BS with additional experience) in quantitative field; advanced SAS skills; CDISC, ICH, GCP, 21 CFR Part 11 knowledge; experience with regulatory submissions; mentoring and vendor management experience.
MapLight TherapeuticsNASDAQ: MPLT: Develops targeted drug therapies for central nervous system disorders.
8+ YOEMaster’s in statistics, computer science or related field; 8+ years statistical programming in pharma/biotech; SAS expert; CDISC SDTM/ADaM; CRO management; FDA/ICH knowledge.
Zenas BioPharmaNASDAQ: ZBIO: Develops transformative therapies for patients with autoimmune diseases.
7+ YOEMaster's in Biostatistics/CS with 7+ years or Bachelor's with 9+ years; strong SAS and CDISC (SDTM/ADaM) knowledge; regulatory filing and ISS/ISE experience; CRO/vendor management and excellent communication.
Sumitomo Pharma AmericaTokyo Stock Exchange: 4506: Developing innovative medicines for neurology, oncology, and rare diseases.
8+ YOE2+ Mgmt8+ years pharma programming with 2+ years of people management; strong SAS, CDISC (SDTM/ADaM), FDA submission experience; leadership and cross-functional collaboration.
SAS, CDISC, SDTM, ADaM, SAS Macros, SAS/Graph, SAS/Stat, R, Shiny
BioNTechNasdaq: BNTX: Develops mRNA-based immunotherapies for cancer and infectious diseases.
5+ YOEBSc in statistics/mathematics/computer science (advanced degree preferred); 5+ years pharma/CRO experience (3+ with advanced degree); strong SAS and SQL skills; CDISC and regulatory submission experience; project management and communication skills.
SAS/Base, SAS Macro, SAS STAT, SAS GRAPH, SQL, CDISC, define.xml, HireRight
Alexion Pharmaceuticals: Develops and manufactures treatments for rare and ultra-rare diseases.
10+ YOE7+ Mgmt10+ years statistical programming in pharma/CRO; 7+ years people/project management; SAS with CDISC ADaM; leadership; regulatory submissions.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
3+ YOEMS or equivalent preferred, 3+ years statistical programming experience in pharma/biotech/CRO, strong SAS (including Base SAS, SAS/STAT, SAS/GRAPH, SAS/SQL, SAS/ODS) and CDISC expertise, EM submission experience, strong communication and critical thinking.